5-ALA not checked
Alpheus Medical, Inc. · 5 Aminolevulinic Acid
FollowEvery change as it happens, and a Monday email
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “standard of care temozolomide + sonosenitizer + sonodynamic therapy”In the company’s words, NCT07225621 on ClinicalTrials.gov
- Tested for
- Glioblastoma (2 trials), GBM (2 trials), Glioblastom WHO Grade 4, bGBM, Butterfly GBM, Bihemispheric GBM
- Main trialPhase 2
- “The purpose of this research is to test an investigational device using ultrasound along with an investigational drug to see if it is useful in treating glioblastoma following standard of care therapy surgery and chemoradiation. This study is evaluating an experimental treatment for glioblastoma that uses an investigational drug (5-ALA) combined with a non-invasive ultrasound device (LIDU) to target tumor cells. Patients meeting the entry requirements to be in the study, will be equally randomly assigned to receive the study device plus the active study drug plus active ultrasound, or to a…”In the company’s words, NCT07225621 on ClinicalTrials.gov
- Other names
- 5 Aminolevulinic Acid · Gleolan
Other drugs for Glioblastoma
- 131I-IPATelix Pharmaceuticals (Innovations) Pty Limited · Phase 3
- SafusidenibNuvation Bio · Phase 3
- Cerebraca waferEverfront Biotech Co., Ltd. · Phase 2/3
- PembrolizumabMerck & Co. · Phase 3
- LAM561Laminar Pharmaceuticals · Phase 2/3
- VebreltinibBeijing Pearl Biotechnology Limited Liability Company · Phase 2/3
Coming up2
- 30 Oct 2027Phase 1 trial completes · ClinicalTrials.gov
- Dec 2027Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Recruiting | Dec 2027 | Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma | |
| Phase 1Recruiting | 30 Oct 2027 | TMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly Glioma | |
| Phase 1Completed | 3 Dec 2024 | Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026